Literature DB >> 8561875

Gamma delta T-cell subset distribution in human semen from fertile donors.

A Bertotto1, F Spinozzi, R Gerli, G Bassotti, G M Fabietti, G Castellucci, C Vagliasindi, R Vaccaro.   

Abstract

PROBLEM: Gamma delta T-cell subset distribution has not been fully investigated in normal human semen.
METHODS: We therefore carried out experiments by using a direct immunofluorescence staining technique followed by two-color cytofluorimetric analysis on mononuclear cell (MC) suspensions from ejaculates of ten healthy, fertile volunteers. Autologous peripheral blood MC were simultaneously analyzed and the results used for statistical comparison.
RESULTS: The proportion of normal human semen lymphocytes bearing the gamma delta T-cell receptor for antigen was greatly increased compared with autologous circulating counterparts. Interestingly, the rise was mainly due to an overexpansion of cells expressing V delta 1 gene-encoded determinants on their surface. This contrasts with the normal blood picture, where most gamma delta T cells express V delta 2 conformational epitopes.
CONCLUSIONS: The numerical and phenotypical differences in semen gamma delta T lymphocytes provide further evidence of a defined migrating lymphocyte subset balance in anatomically and physiologically distinct areas of the body. Their functional role, in terms of both helper and suppressor-cytotoxic activities in the nonsterile proximal portions of the male genital tract, now needs to be explored in detail.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561875     DOI: 10.1111/j.1600-0897.1995.tb00935.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  1 in total

1.  Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men.

Authors:  Mohammad Reza Zamani; Firouzeh Akbari Asbagh; Amir Hossein Massoud; Arash Salmaninejad; Ahmad Massoud; Nima Rezaei
Journal:  J Assist Reprod Genet       Date:  2014-11-16       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.